These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5410848)

  • 1. Tolerance to polyinosinic-polycytidylic acid in NZB-NZW mice.
    Steinberg AD; Daley GG; Talal N
    Science; 1970 Feb; 167(3919):870-1. PubMed ID: 5410848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid.
    Steinberg AD; Baron S; Talal N
    Proc Natl Acad Sci U S A; 1969 Aug; 63(4):1102-7. PubMed ID: 5307809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide tolerance as a test for antigenicity of nucleic acids.
    Steinberg AD; Chused TM; Jacobs ME; Talal N
    Nature; 1970 Dec; 228(5276):1090. PubMed ID: 5483164
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of antigodies binding polyinosinic-polycytidylic acid in human and mouse lupus sera by viral and synthetic ribonucleic acids.
    Talal N; Steinberg AD; Daley GG
    J Clin Invest; 1971 Jun; 50(6):1248-52. PubMed ID: 4325310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of antibodies to nucleic acids with polyinosinic-polycytidylic acid and cyclophosphamide in murine lupus.
    Steinberg AD; Talal N
    Clin Exp Immunol; 1970 Nov; 7(5):687-91. PubMed ID: 5493526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific immunosuppression, polyinosinic--polycytidylic acid, and viruses in New Zealand mice.
    Talal N; Steinberg AD; Gazdar AF
    Fed Proc; 1971; 30(6):1842-5. PubMed ID: 4330992
    [No Abstract]   [Full Text] [Related]  

  • 7. T-cell tolerance induction is normal in the (NZB x NZW)F1 murine model of systemic lupus erythematosus.
    Wither J; Vukusic B
    Immunology; 2000 Mar; 99(3):345-51. PubMed ID: 10712663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between dose size and dose interval of polyinosinic polycytidylic acid and interferon hyporesponsiveness in mice.
    DuBuy HG; Johnson ML; Buckler CE; Baron S
    Proc Soc Exp Biol Med; 1970 Nov; 135(2):340-4. PubMed ID: 5479996
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiviral comparisons of statolon and polyinosinic-polycytidylic acid.
    Mayer GD; Krueger RF
    Antimicrob Agents Chemother (Bethesda); 1969; 9():182-6. PubMed ID: 5407772
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of polyinosinic:polycytidylic acid on tumor metabolism.
    Levy HB; Riley F
    Proc Soc Exp Biol Med; 1970 Oct; 135(1):141-5. PubMed ID: 4920170
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhancement of interferon synthesis by polyinosinic-polycytidylic acid in L cells pretreated with interferon.
    Rosztóczy I; Mécs I
    Acta Virol; 1970 Sep; 14(5):398-400. PubMed ID: 4394666
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA.
    Gilkeson GS; Pippen AM; Pisetsky DS
    J Clin Invest; 1995 Mar; 95(3):1398-402. PubMed ID: 7883986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice.
    Carlsten H; Holmdahl R; Tarkowski A
    Immunology; 1991 Jun; 73(2):186-90. PubMed ID: 2071164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of humoral and cellular antibody formation in mice by poly Ir:Cr.
    Turner W; Chan SP; Chirigos MA
    Proc Soc Exp Biol Med; 1970 Jan; 133(1):334-8. PubMed ID: 4904563
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunologic studies of autoimmune disease in NZB-NZW F1 mice. I. Binding of fluorescein-labeled antinucleoside antibodies in lesions of lupus-like nephritis.
    Seegal BC; Accinni L; Andres GA; Beiser SM; Christian CL; Erlanger BF; Hsu K
    J Exp Med; 1969 Aug; 130(2):203-16. PubMed ID: 4183483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB × NZW)F1 systemic lupus erythematosus model.
    Zhang M; Yu G; Chan B; Pearson JT; Rathanaswami P; Delaney J; Ching Lim A; Babcook J; Hsu H; Gavin MA
    Arthritis Rheumatol; 2015 Oct; 67(10):2723-31. PubMed ID: 26097207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB x NZW)F(1) lupus mice.
    Monneaux F; Dumortier H; Steiner G; Briand JP; Muller S
    Int Immunol; 2001 Sep; 13(9):1155-63. PubMed ID: 11526096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant genetic control of invariant TCR-bearing NKT cell function in New Zealand mouse strains: possible involvement in systemic lupus erythematosus pathogenesis.
    Tsukamoto K; Ohtsuji M; Shiroiwa W; Lin Q; Nakamura K; Tsurui H; Jiang Y; Sudo K; Nishimura H; Shirai T; Hirose S
    J Immunol; 2008 Apr; 180(7):4530-9. PubMed ID: 18354175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro production of anti-histone antibodies in NZB/NZW mice.
    Gioud M; Kotzin BL; Rubin RL; Joslin FG; Tan EM
    J Immunol; 1983 Jul; 131(1):269-74. PubMed ID: 6863918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice.
    Foell J; Strahotin S; O'Neil SP; McCausland MM; Suwyn C; Haber M; Chander PN; Bapat AS; Yan XJ; Chiorazzi N; Hoffmann MK; Mittler RS
    J Clin Invest; 2003 May; 111(10):1505-18. PubMed ID: 12750400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.